nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—SLC7A5—Balsalazide—Sulfasalazine—ankylosing spondylitis	0.0365	0.534	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00555	0.0812	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00546	0.08	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00546	0.08	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00533	0.0781	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—ankylosing spondylitis	0.00506	0.0741	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00494	0.0724	CbGdCrCtD
L-DOPA—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00281	0.00302	CcSEcCtD
L-DOPA—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00281	0.00302	CcSEcCtD
L-DOPA—Malaise—Prednisolone—ankylosing spondylitis	0.00278	0.00298	CcSEcCtD
L-DOPA—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00278	0.00298	CcSEcCtD
L-DOPA—Syncope—Prednisolone—ankylosing spondylitis	0.00276	0.00297	CcSEcCtD
L-DOPA—Back pain—Triamcinolone—ankylosing spondylitis	0.00274	0.00294	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00271	0.00291	CcSEcCtD
L-DOPA—Convulsion—Prednisolone—ankylosing spondylitis	0.00267	0.00287	CcSEcCtD
L-DOPA—Hypertension—Prednisolone—ankylosing spondylitis	0.00266	0.00286	CcSEcCtD
L-DOPA—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00264	0.00283	CcSEcCtD
L-DOPA—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00264	0.00283	CcSEcCtD
L-DOPA—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00263	0.00282	CcSEcCtD
L-DOPA—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00262	0.00282	CcSEcCtD
L-DOPA—Alopecia—Dexamethasone—ankylosing spondylitis	0.00261	0.0028	CcSEcCtD
L-DOPA—Alopecia—Betamethasone—ankylosing spondylitis	0.00261	0.0028	CcSEcCtD
L-DOPA—Discomfort—Prednisolone—ankylosing spondylitis	0.00259	0.00278	CcSEcCtD
L-DOPA—Angioedema—Triamcinolone—ankylosing spondylitis	0.00259	0.00278	CcSEcCtD
L-DOPA—Haemoglobin—Prednisone—ankylosing spondylitis	0.00259	0.00278	CcSEcCtD
L-DOPA—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00258	0.00277	CcSEcCtD
L-DOPA—Haemorrhage—Prednisone—ankylosing spondylitis	0.00257	0.00276	CcSEcCtD
L-DOPA—Hallucination—Prednisone—ankylosing spondylitis	0.00256	0.00275	CcSEcCtD
L-DOPA—Malaise—Triamcinolone—ankylosing spondylitis	0.00256	0.00274	CcSEcCtD
L-DOPA—Malaise—Methylprednisolone—ankylosing spondylitis	0.00255	0.00274	CcSEcCtD
L-DOPA—Syncope—Triamcinolone—ankylosing spondylitis	0.00254	0.00273	CcSEcCtD
L-DOPA—Syncope—Methylprednisolone—ankylosing spondylitis	0.00254	0.00272	CcSEcCtD
L-DOPA—Oedema—Prednisolone—ankylosing spondylitis	0.00252	0.0027	CcSEcCtD
L-DOPA—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.0025	0.00268	CcSEcCtD
L-DOPA—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00249	0.00267	CcSEcCtD
L-DOPA—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00249	0.00267	CcSEcCtD
L-DOPA—Shock—Prednisolone—ankylosing spondylitis	0.00248	0.00266	CcSEcCtD
L-DOPA—Cough—Triamcinolone—ankylosing spondylitis	0.00247	0.00265	CcSEcCtD
L-DOPA—Convulsion—Triamcinolone—ankylosing spondylitis	0.00246	0.00264	CcSEcCtD
L-DOPA—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00245	0.00263	CcSEcCtD
L-DOPA—Hypertension—Triamcinolone—ankylosing spondylitis	0.00245	0.00263	CcSEcCtD
L-DOPA—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00244	0.00262	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00243	0.00261	CcSEcCtD
L-DOPA—Anxiety—Methylprednisolone—ankylosing spondylitis	0.0024	0.00258	CcSEcCtD
L-DOPA—Depression—Methotrexate—ankylosing spondylitis	0.00239	0.00256	CcSEcCtD
L-DOPA—Flushing—Prednisone—ankylosing spondylitis	0.00239	0.00256	CcSEcCtD
L-DOPA—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00239	0.00256	CcSEcCtD
L-DOPA—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00239	0.00256	CcSEcCtD
L-DOPA—Discomfort—Triamcinolone—ankylosing spondylitis	0.00238	0.00256	CcSEcCtD
L-DOPA—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00238	0.00255	CcSEcCtD
L-DOPA—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00236	0.00253	CcSEcCtD
L-DOPA—Angioedema—Dexamethasone—ankylosing spondylitis	0.00235	0.00252	CcSEcCtD
L-DOPA—Angioedema—Betamethasone—ankylosing spondylitis	0.00235	0.00252	CcSEcCtD
L-DOPA—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00233	0.0025	CcSEcCtD
L-DOPA—Malaise—Dexamethasone—ankylosing spondylitis	0.00232	0.00249	CcSEcCtD
L-DOPA—Malaise—Betamethasone—ankylosing spondylitis	0.00232	0.00249	CcSEcCtD
L-DOPA—Oedema—Triamcinolone—ankylosing spondylitis	0.00231	0.00248	CcSEcCtD
L-DOPA—Syncope—Betamethasone—ankylosing spondylitis	0.00231	0.00248	CcSEcCtD
L-DOPA—Syncope—Dexamethasone—ankylosing spondylitis	0.00231	0.00248	CcSEcCtD
L-DOPA—Arrhythmia—Prednisone—ankylosing spondylitis	0.0023	0.00247	CcSEcCtD
L-DOPA—Shock—Triamcinolone—ankylosing spondylitis	0.00228	0.00244	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—ankylosing spondylitis	0.00228	0.00244	CcSEcCtD
L-DOPA—Alopecia—Prednisone—ankylosing spondylitis	0.00227	0.00244	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—ankylosing spondylitis	0.00227	0.00244	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00226	0.00243	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00226	0.00243	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00226	0.00242	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—ankylosing spondylitis	0.00225	0.00242	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00224	0.0024	CcSEcCtD
L-DOPA—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00224	0.0024	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00223	0.0024	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—ankylosing spondylitis	0.00223	0.00239	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—ankylosing spondylitis	0.00223	0.00239	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—ankylosing spondylitis	0.00222	0.00238	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—ankylosing spondylitis	0.00222	0.00238	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—ankylosing spondylitis	0.00218	0.00234	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
L-DOPA—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00216	0.00232	CcSEcCtD
L-DOPA—Pain—Prednisolone—ankylosing spondylitis	0.00215	0.00231	CcSEcCtD
L-DOPA—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00215	0.00231	CcSEcCtD
L-DOPA—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00212	0.00228	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—ankylosing spondylitis	0.00211	0.00227	CcSEcCtD
L-DOPA—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00211	0.00226	CcSEcCtD
L-DOPA—Oedema—Betamethasone—ankylosing spondylitis	0.0021	0.00225	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—ankylosing spondylitis	0.0021	0.00225	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—ankylosing spondylitis	0.00209	0.00225	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00209	0.00224	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00208	0.00223	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00208	0.00223	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00207	0.00223	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00207	0.00222	CcSEcCtD
L-DOPA—Anaemia—Prednisone—ankylosing spondylitis	0.00207	0.00222	CcSEcCtD
L-DOPA—Shock—Dexamethasone—ankylosing spondylitis	0.00207	0.00222	CcSEcCtD
L-DOPA—Shock—Betamethasone—ankylosing spondylitis	0.00207	0.00222	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00206	0.00221	CcSEcCtD
L-DOPA—Agitation—Prednisone—ankylosing spondylitis	0.00206	0.00221	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00206	0.00221	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00206	0.00221	CcSEcCtD
L-DOPA—Angioedema—Prednisone—ankylosing spondylitis	0.00205	0.0022	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00204	0.00219	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00203	0.00218	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00203	0.00218	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00203	0.00218	CcSEcCtD
L-DOPA—Malaise—Prednisone—ankylosing spondylitis	0.00202	0.00217	CcSEcCtD
L-DOPA—Syncope—Prednisone—ankylosing spondylitis	0.00201	0.00216	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—ankylosing spondylitis	0.002	0.00215	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—ankylosing spondylitis	0.002	0.00215	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—ankylosing spondylitis	0.002	0.00215	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—ankylosing spondylitis	0.00199	0.00214	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00199	0.00214	CcSEcCtD
L-DOPA—Pain—Triamcinolone—ankylosing spondylitis	0.00198	0.00212	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00197	0.00211	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—ankylosing spondylitis	0.00196	0.00211	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—ankylosing spondylitis	0.00196	0.00211	CcSEcCtD
L-DOPA—Convulsion—Prednisone—ankylosing spondylitis	0.00194	0.00208	CcSEcCtD
L-DOPA—Hypertension—Prednisone—ankylosing spondylitis	0.00193	0.00208	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00191	0.00205	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0019	0.00204	CcSEcCtD
L-DOPA—Anxiety—Prednisone—ankylosing spondylitis	0.0019	0.00204	CcSEcCtD
L-DOPA—Alopecia—Methotrexate—ankylosing spondylitis	0.0019	0.00204	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—ankylosing spondylitis	0.0019	0.00204	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—ankylosing spondylitis	0.0019	0.00204	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00189	0.00203	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
L-DOPA—Discomfort—Prednisone—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
L-DOPA—Mental disorder—Methotrexate—ankylosing spondylitis	0.00188	0.00202	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00185	0.00199	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00185	0.00198	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00185	0.00198	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—ankylosing spondylitis	0.00184	0.00197	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00183	0.00197	CcSEcCtD
L-DOPA—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00183	0.00197	CcSEcCtD
L-DOPA—Oedema—Prednisone—ankylosing spondylitis	0.00183	0.00196	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00182	0.00196	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00182	0.00196	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00182	0.00196	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00181	0.00195	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00181	0.00195	CcSEcCtD
L-DOPA—Back pain—Methotrexate—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—ankylosing spondylitis	0.00181	0.00194	CcSEcCtD
L-DOPA—Shock—Prednisone—ankylosing spondylitis	0.0018	0.00193	CcSEcCtD
L-DOPA—Pain—Betamethasone—ankylosing spondylitis	0.0018	0.00193	CcSEcCtD
L-DOPA—Pain—Dexamethasone—ankylosing spondylitis	0.0018	0.00193	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00177	0.0019	CcSEcCtD
L-DOPA—Vision blurred—Methotrexate—ankylosing spondylitis	0.00176	0.00189	CcSEcCtD
L-DOPA—Anorexia—Prednisone—ankylosing spondylitis	0.00174	0.00187	CcSEcCtD
L-DOPA—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00174	0.00186	CcSEcCtD
L-DOPA—Anaemia—Methotrexate—ankylosing spondylitis	0.00173	0.00186	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00173	0.00186	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00173	0.00186	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00172	0.00184	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00172	0.00184	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0017	0.00183	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.0017	0.00183	CcSEcCtD
L-DOPA—Malaise—Methotrexate—ankylosing spondylitis	0.00169	0.00181	CcSEcCtD
L-DOPA—Leukopenia—Methotrexate—ankylosing spondylitis	0.00168	0.0018	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—ankylosing spondylitis	0.00167	0.00179	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—ankylosing spondylitis	0.00167	0.00179	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—ankylosing spondylitis	0.00166	0.00179	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—ankylosing spondylitis	0.00166	0.00178	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00166	0.00178	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00166	0.00178	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00166	0.00178	CcSEcCtD
L-DOPA—Insomnia—Prednisone—ankylosing spondylitis	0.00165	0.00177	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—ankylosing spondylitis	0.00164	0.00176	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—ankylosing spondylitis	0.00164	0.00176	CcSEcCtD
L-DOPA—Cough—Methotrexate—ankylosing spondylitis	0.00163	0.00175	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00163	0.00175	CcSEcCtD
L-DOPA—Convulsion—Methotrexate—ankylosing spondylitis	0.00162	0.00174	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—ankylosing spondylitis	0.00161	0.00173	CcSEcCtD
L-DOPA—Chest pain—Methotrexate—ankylosing spondylitis	0.00159	0.00171	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—ankylosing spondylitis	0.00159	0.00171	CcSEcCtD
L-DOPA—Rash—Prednisolone—ankylosing spondylitis	0.00159	0.0017	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—ankylosing spondylitis	0.00158	0.0017	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00158	0.0017	CcSEcCtD
L-DOPA—Fatigue—Prednisone—ankylosing spondylitis	0.00158	0.00169	CcSEcCtD
L-DOPA—Headache—Prednisolone—ankylosing spondylitis	0.00158	0.00169	CcSEcCtD
L-DOPA—Discomfort—Methotrexate—ankylosing spondylitis	0.00157	0.00169	CcSEcCtD
L-DOPA—Constipation—Prednisone—ankylosing spondylitis	0.00156	0.00168	CcSEcCtD
L-DOPA—Confusional state—Methotrexate—ankylosing spondylitis	0.00154	0.00165	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00153	0.00164	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—ankylosing spondylitis	0.00151	0.00162	CcSEcCtD
L-DOPA—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.0015	0.00161	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00149	0.0016	CcSEcCtD
L-DOPA—Nausea—Prednisolone—ankylosing spondylitis	0.00149	0.0016	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—ankylosing spondylitis	0.00149	0.00159	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—ankylosing spondylitis	0.00149	0.00159	CcSEcCtD
L-DOPA—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00148	0.00159	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—ankylosing spondylitis	0.00147	0.00158	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00147	0.00158	CcSEcCtD
L-DOPA—Rash—Triamcinolone—ankylosing spondylitis	0.00146	0.00157	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00146	0.00156	CcSEcCtD
L-DOPA—Anorexia—Methotrexate—ankylosing spondylitis	0.00146	0.00156	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—ankylosing spondylitis	0.00146	0.00156	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00145	0.00156	CcSEcCtD
L-DOPA—Urticaria—Prednisone—ankylosing spondylitis	0.00145	0.00156	CcSEcCtD
L-DOPA—Headache—Triamcinolone—ankylosing spondylitis	0.00145	0.00156	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—ankylosing spondylitis	0.00145	0.00155	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—ankylosing spondylitis	0.00145	0.00155	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00144	0.00154	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00144	0.00154	CcSEcCtD
L-DOPA—Hypotension—Methotrexate—ankylosing spondylitis	0.00143	0.00153	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—ankylosing spondylitis	0.00139	0.00149	CcSEcCtD
L-DOPA—Insomnia—Methotrexate—ankylosing spondylitis	0.00138	0.00148	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—ankylosing spondylitis	0.00137	0.00147	CcSEcCtD
L-DOPA—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00137	0.00147	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—ankylosing spondylitis	0.00137	0.00147	CcSEcCtD
L-DOPA—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00136	0.00146	CcSEcCtD
L-DOPA—Somnolence—Methotrexate—ankylosing spondylitis	0.00136	0.00146	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00135	0.00145	CcSEcCtD
L-DOPA—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00134	0.00144	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—ankylosing spondylitis	0.00133	0.00143	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—ankylosing spondylitis	0.00133	0.00143	CcSEcCtD
L-DOPA—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00133	0.00143	CcSEcCtD
L-DOPA—Rash—Betamethasone—ankylosing spondylitis	0.00132	0.00142	CcSEcCtD
L-DOPA—Rash—Dexamethasone—ankylosing spondylitis	0.00132	0.00142	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00132	0.00142	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—ankylosing spondylitis	0.00132	0.00142	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00132	0.00142	CcSEcCtD
L-DOPA—Fatigue—Methotrexate—ankylosing spondylitis	0.00132	0.00141	CcSEcCtD
L-DOPA—Headache—Dexamethasone—ankylosing spondylitis	0.00132	0.00141	CcSEcCtD
L-DOPA—Headache—Betamethasone—ankylosing spondylitis	0.00132	0.00141	CcSEcCtD
L-DOPA—Asthenia—Prednisone—ankylosing spondylitis	0.00131	0.00141	CcSEcCtD
L-DOPA—Pain—Methotrexate—ankylosing spondylitis	0.00131	0.0014	CcSEcCtD
L-DOPA—Pruritus—Prednisone—ankylosing spondylitis	0.00129	0.00139	CcSEcCtD
L-DOPA—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00126	0.00135	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—ankylosing spondylitis	0.00125	0.00134	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00125	0.00134	CcSEcCtD
L-DOPA—Nausea—Betamethasone—ankylosing spondylitis	0.00125	0.00134	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—ankylosing spondylitis	0.00125	0.00134	CcSEcCtD
L-DOPA—Urticaria—Methotrexate—ankylosing spondylitis	0.00121	0.0013	CcSEcCtD
L-DOPA—Dizziness—Prednisone—ankylosing spondylitis	0.00121	0.0013	CcSEcCtD
L-DOPA—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00121	0.0013	CcSEcCtD
L-DOPA—Vomiting—Prednisone—ankylosing spondylitis	0.00116	0.00125	CcSEcCtD
L-DOPA—Rash—Prednisone—ankylosing spondylitis	0.00115	0.00124	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—ankylosing spondylitis	0.00115	0.00124	CcSEcCtD
L-DOPA—Headache—Prednisone—ankylosing spondylitis	0.00115	0.00123	CcSEcCtD
L-DOPA—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00113	0.00121	CcSEcCtD
L-DOPA—Asthenia—Methotrexate—ankylosing spondylitis	0.0011	0.00118	CcSEcCtD
L-DOPA—Nausea—Prednisone—ankylosing spondylitis	0.00109	0.00117	CcSEcCtD
L-DOPA—Pruritus—Methotrexate—ankylosing spondylitis	0.00108	0.00116	CcSEcCtD
L-DOPA—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00105	0.00112	CcSEcCtD
L-DOPA—Dizziness—Methotrexate—ankylosing spondylitis	0.00101	0.00108	CcSEcCtD
L-DOPA—Vomiting—Methotrexate—ankylosing spondylitis	0.000971	0.00104	CcSEcCtD
L-DOPA—Rash—Methotrexate—ankylosing spondylitis	0.000963	0.00103	CcSEcCtD
L-DOPA—Dermatitis—Methotrexate—ankylosing spondylitis	0.000962	0.00103	CcSEcCtD
L-DOPA—Headache—Methotrexate—ankylosing spondylitis	0.000957	0.00103	CcSEcCtD
L-DOPA—Nausea—Methotrexate—ankylosing spondylitis	0.000907	0.000974	CcSEcCtD
